2021
Dougherty C, Friedman BW, Aurora S, Bariahtaris S, Shrewsbury S, Baker-Wagner M, Sacks N , Kautz S, Cyr P . Impact of INP104 on healthcare resource use among patients in STOP 301. Presentation at American Academy of Neurology Annual Meeting, Virtual, April 2021.
Publication: Abstracts and Presentations
Dougherty C, Friedman BW, Aurora S, Bariahtaris S, Shrewsbury S, Baker-Wagner M, Sacks N , Kautz S, Cyr P . INP104 reduces self-reported ED and urgent care in patients with episodic migraine. Presentation at Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Virtual, April 2021.
Publication: Abstracts and Presentations
Sacks NC , Healey B, Cyr PL , Slocomb T, James E, Beggs A, Graham RJ. Healthcare resource use and expenditures in patients with x-linked myotubular myopathy (XLMTM). Poster presentation, ISPOR 25th Annual International Meeting, Orlando, FL, April 2021.
Publication: Abstracts and Presentations
Panattoni L, Hernandez J, Liu Y , Sacks NC , Higham R, Stephenson B, Armstrong A. Initial treatment patterns for newly diagnosed, commercially insured patients with psoriasis. Poster presentation, ISPOR, April 2021.
Publication: Abstracts and Presentations
Niu X, Veeranki S, Dennen S, Liu Y , Shafrin J, Dembek C, Laubmeier K, Williams GR. Hospitalization risk among adults with bipolar I disorder treated with oral atypical antipsychotics: A long-term data analysis of Medicaid claims data. Abstract, CNS Spectrums 26(2):172-173; doi: 10.1017/S1092852920002813 . April, 2021.
View Abstract
Publication: Abstracts and Presentations
Chew D, Sacks NC , Emden MR, Preib MT, Cyr PL , Wood D, Pokorney SD. 2021. Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States. Am Heart J 233(March):132–140; doi: 10.1016/j.ahj.2020.12.012 . PMID: 33359780.
View Abstract
Publication: Manuscripts
Dean R, Jensen IS, Cyr PL , Miller B , Maru B, Sproule DM, Feltner DE, et al. 2021. An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER). J Mark Access Health Pol 9(1):1889841; doi: 10.1080/20016689.2021.1889841 . PMID: 33708361.
View Abstract
Publication: Manuscripts
Hathway J, Miller-Wilson L, Yao W, Jensen I , Weinstein M, Parks P. 2021. The health economic impact of varying levels of adherence to colorectal screening on providers and payers. J Med Econ 24(1):69–78; doi: 10.1080/13696998.2020.1858607 . PMID: 33970747.
View Abstract
Publication: Manuscripts
2020
Miller B , Yao W, Dean R, Jensen IS, Cyr PL , Slocomb T. 2020. Abstract PMS57: Understanding the impact of XLMTM on parents and caregivers in the US: An analysis of survey results. Value in Health 23(Sup 2):S601; doi: 10.1016/j.jval.2020.08.1188 .
View Abstract
Publication: Abstracts and Presentations
Cohen SS, Roger VL, Weston SA, Jiang R, Movva N , Yusuf AA, Chamberlain AM. 2020. Evaluation of claims-based computable phenotypes to identify heart failure patients with preserved ejection fraction. Pharmacol Res Persp 8(6):e00676; doi: 10.1002/prp2.676 . PMID: 33124771.
View Abstract
A Division of